This particular project has taken three years to work on, and it involves researching a lung cancer “biomarker signature” which can be detected in one’s breath itself. Studies in the past point to carbon-based sensors which have been embedded with gold nanoparticles to be able to indicate the disease in the lungs, not to mention dogs with their acute sense of smell, too, can also detect chemicals in one’s breath that points towards the presence of the disease. Having secured £105,000 in funding from the SG Court Pharmacy Group, folks should soon be able to find such trial breathalyzers dot the chain of pharmacies in the South East of England. After all, with most folks being a whole lot more comfortable at a pharmacy than at the doctor’s room, it might just boost the chances of an early detection.